Related Experiment Video
Updated: Mar 17, 2026

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
Published on: April 6, 2016
Toward an Optimal Approach for Variable Selection in Counter-Propagation Neural Networks: Modeling Protein-Tyrosine
Bahram Hemmateenejad1,2, Ahmadreza Mehdipour2, Omar Deeb3
1Department of Chemistry, Shiraz University, Shiraz, Iran.
Abstract:
Counter propagation neural network (CPNN) is one of the attractive tools of classification in QSAR studies. A major obstacle in classification by CPNN is finding the best subset of variables. In this study, the performance of some different feature selection algorithms including F score-based ranking, eigenvalue ranking of PCs obtained from data set, Non-Error-Rate (NER) ranking of both descriptors and PCs, and 3-way handling of data, Parallel Factor Analysis (PARAFAC), was evaluated in order to find the best classification model. The methods were applied for modeling protein-tyrosine kinase inhibitory of some flavonoid derivatives using substituent electronic descriptors (SED) as novel source of electronic descriptors. The results showed that the best performance was achieved by F-score ranking while the NER ranking of principal components (PCs) showed very fluctuate results and the worst performance was belonging to PARAFAC-CPNN. Furthermore, comparison of results of these nonlinear algorithms with linear discriminate analysis method revealed better predictions by the former.
Related Concept Videos
Pharmacodynamic Models: Additive and Proportional Drug Effect Model
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Protein-Drug Binding: Mechanism and Kinetics
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Pharmacodynamic Models: Overview
Physiological Pharmacokinetic Models: Assumption with Protein Binding
Pharmacodynamic Models: Direct Effect Model and Indirect Response Model

